Danish Biotech Genmab A/S to Reorganize, to Sell U.S. Plant and Cut 300 Jobs

STOCKHOLM (Dow Jones)--Danish pharmaceutical company Genmab A/S (GEN.KO) said Thursday it will cut around 300 jobs, sell its U.S.-based manufacturing facility and reorganize its business in order to “match resources to ongoing and future needs”.